StonvexLoading…
StonvexStonvexStonvexCore line items from OM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $119.48M | $113.69M | $130.38M | $115.38M |
Operating Income | $-66.71M | $-113.38M | $-169.77M | $-161.02M |
Net Income | $-81.65M | $-127.98M | $-172.80M | $-162.96M |
EPS (Diluted) | $-5.37 | $-36.96 | $-52.28 | $-3.38 |
Total Assets | $264.50M | $275.80M | $313.80M | $400.12M |
Total Liabilities | $137.54M | $248.98M | $190.91M | $154.13M |
Cash & Equivalents | $35.01M | $124.01M | $68.51M | $73.22M |
Free Cash Flow OCF − CapEx | $-47.13M | $-117.22M | $-134.81M | $-154.05M |
Shares Outstanding | 18.17M | 3.53M | 50.32M | 48.47M |